GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Marketable Securities

Akeso (AKESF) Marketable Securities : $58.5 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Akeso Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Akeso's Marketable Securities for the quarter that ended in Dec. 2024 was $58.5 Mil.

Akeso's annual Marketable Securities increased from Dec. 2022 ($28.1 Mil) to Dec. 2023 ($119.4 Mil) but then declined from Dec. 2023 ($119.4 Mil) to Dec. 2024 ($58.5 Mil).

Akeso Marketable Securities Historical Data

The historical data trend for Akeso's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Marketable Securities Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial 16.82 - 28.10 119.39 58.48

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.10 72.33 119.39 67.12 58.48

Akeso Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Akeso  (OTCPK:AKESF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Akeso Marketable Securities Related Terms

Thank you for viewing the detailed overview of Akeso's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Marketable Securities
Comparable Companies
HKSE:06990 HKSE:01177 HKSE:02269 HKSE:01530 HKSE:01801 HKSE:09995 HKSE:01877 HKSE:01548 HKSE:02696 HKSE:06855 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
09926:Hong Kong 4RY:Germany
Address
No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Website
https://www.akesobio.com
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China, and also has its presence in USA and Other regions.